{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:25:28Z","timestamp":1791239128026,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.ejphar.2007.12.036","type":"journal-article","created":{"date-parts":[[2008,2,15]],"date-time":"2008-02-15T07:34:45Z","timestamp":1203060885000},"page":"192-201","source":"Crossref","is-referenced-by-count":30,"title":["A novel selective peroxisome proliferator-activator receptor-\u03b3 modulator\u2014SPPAR\u03b3M5 improves insulin sensitivity with diminished adverse cardiovascular effects"],"prefix":"10.1016","volume":"584","author":[{"given":"Ching H.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret S.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S.","family":"Muise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold B.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Meinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W.","family":"Doebber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel P.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.12.036_bib1","series-title":"Takeda Pharmaceutical America, Inc., Lincolnshire, IL., USA","author":"Actos\u00ae package insert","year":"2003"},{"key":"10.1016\/j.ejphar.2007.12.036_bib2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1124\/jpet.102.042648","article-title":"Mechanism and implications of brown adipose tissue proliferation in rats and monkeys treated with the thiazolidinedione darglitazone, a potent peroxisome proliferator-activated receptor-gamma agonist","volume":"305","author":"Aleo","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.12.036_bib3","series-title":"GlaxoSmithKline, Research Triangle Park, NC, USA","author":"Avandia\u00ae package insert","year":"2003"},{"key":"10.1016\/j.ejphar.2007.12.036_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1113\/jphysiol.1957.sp005875","article-title":"Studies of plasma volume, red cell volume and total blood volume in young growing rats","volume":"139","author":"Belcher","year":"1957","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2007.12.036_bib39","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.1074\/jbc.274.10.6718","article-title":"Novel PPAR\u03b3 and PPAR\u03b4 ligands produce distinct biological effects","volume":"274","author":"Berger","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2007.12.036_bib5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/me.2002-0217","article-title":"Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator","volume":"17","author":"Berger","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2007.12.036_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.tips.2005.03.003","article-title":"PPARs: therapeutic targets for metabolic disease","volume":"26","author":"Berger","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2007.12.036_bib7","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/me.2005-0171","article-title":"A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro","volume":"20","author":"Burgermeister","year":"2006","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2007.12.036_bib8","doi-asserted-by":"crossref","first-page":"E449","DOI":"10.1152\/ajpendo.00329.2003","article-title":"Treatment of type 2 diabetic db\/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function","volume":"286","author":"Carley","year":"2004","journal-title":"Am. J. Physiol: Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2007.12.036_bib9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1124\/jpet.104.074088","article-title":"GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats","volume":"312","author":"Chen","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.12.036_bib10","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.12.036_bib11","first-page":"159","article-title":"Evaluation of multiple frequency bioelectrical impedance and Cole\u2013Cole analysis for the assessment of body water volumes in healthy humans","volume":"50","author":"Cornish","year":"1996","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2007.12.036_bib12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.RES.0000179226.34112.6d","article-title":"Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice","volume":"97","author":"Duan","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2007.12.036_bib13","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1210\/en.142.10.4195","article-title":"Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding","volume":"142","author":"Escher","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2007.12.036_bib14","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.RES.0000060700.55247.7C","article-title":"Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta\/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism","volume":"92","author":"Gilde","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2007.12.036_bib15","first-page":"F1013","article-title":"Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans","volume":"273","author":"Guan","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.12.036_bib16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nm1278","article-title":"Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption","volume":"11","author":"Guan","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2007.12.036_bib17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/86730","article-title":"Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer","volume":"19","author":"Hughes","year":"2001","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejphar.2007.12.036_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00043798-200108000-00005","article-title":"PPARS, insulin resistance and type 2 diabetes","volume":"8","author":"Kaplan","year":"2001","journal-title":"J. Cardiovasc. Risk"},{"key":"10.1016\/j.ejphar.2007.12.036_bib19","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/ajhp\/61.4.390","article-title":"Prevalence of edema in patients receiving combination therapy with insulin and thiazolidinedione","volume":"61","author":"King","year":"2004","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.ejphar.2007.12.036_bib40","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.2337\/db06-0551","article-title":"Mechanisms of the depot specificity of peroxisome proliferator-activated receptor gamma action on adipose tissue metabolism","volume":"55","author":"Laplante","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2007.12.036_bib20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1210\/rp.56.1.265","article-title":"Insulin resistance and its treatment by thiazolidinediones","volume":"56","author":"Lebovitz","year":"2001","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.ejphar.2007.12.036_bib21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2007.12.036_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejphar.2004.04.038","article-title":"Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614","volume":"494","author":"Minoura","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.12.036_bib23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/jpet.103.049791","article-title":"PAT5A: a partial agonist of peroxisome proliferator-activated receptor gamma is a potent antidiabetic thiazolidinedione yet weakly adipogenic","volume":"306","author":"Misra","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.12.036_bib24","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1210\/me.14.9.1425","article-title":"A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes","volume":"14","author":"Mukherjee","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2007.12.036_bib25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/diacare.27.1.256","article-title":"Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association","volume":"27","author":"Nesto","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2007.12.036_bib26","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1592\/phco.22.11.924.33626","article-title":"Thiazolidinedione-induced edema","volume":"22","author":"Niemeyer","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2007.12.036_bib27","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1073\/pnas.96.11.6102","article-title":"A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation","volume":"96","author":"Oberfield","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2007.12.036_bib28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1043-2760(00)00306-4","article-title":"PPAR gamma and the treatment of insulin resistance","volume":"11","author":"Olefsky","year":"2000","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2007.12.036_bib29","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/sj.bjp.0702932","article-title":"Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution","volume":"128","author":"Pickavance","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.12.036_bib30","series-title":"Warner Lambert Company, Morris Plains, NJ, USA","author":"Rezulin\u00ae package insert","year":"1997"},{"key":"10.1016\/j.ejphar.2007.12.036_bib31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1097-2765(01)00353-7","article-title":"A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity","volume":"8","author":"Rocchi","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2007.12.036_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1258\/002367798780559356","article-title":"Bioelectrical impedance analysis for the estimation of body composition in rats","volume":"32","author":"Rutter","year":"1998","journal-title":"Lab. Anim."},{"key":"10.1016\/j.ejphar.2007.12.036_bib33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1124\/jpet.103.058008","article-title":"Rosiglitazone activates renal sodium- and water-reabsorptive pathways and lowers blood pressure in normal rats","volume":"308","author":"Song","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.12.036_bib34","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1172\/JCI118703","article-title":"Regulation of PPAR gamma gene expression by nutrition and obesity in rodents","volume":"97","author":"Vidal-Puig","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2007.12.036_bib35","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1592\/phco.21.13.1082.34615","article-title":"A review of rosiglitazone in type 2 diabetes mellitus","volume":"21","author":"Werner","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2007.12.036_bib36","first-page":"F966","article-title":"Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney","volume":"277","author":"Yang","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.12.036_bib37","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1210\/me.10.11.1457","article-title":"Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha","volume":"10","author":"Zhang","year":"1996","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2007.12.036_bib38","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1073\/pnas.0501744102","article-title":"Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908000897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299908000897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T22:44:20Z","timestamp":1557269060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299908000897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0014299908000897"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.12.036","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}